药物发现
自然(考古学)
人类健康
抗菌剂
生物技术
生物
基因组
计算生物学
生化工程
生物信息学
工程类
医学
微生物学
生物化学
基因
古生物学
环境卫生
作者
Kou‐San Ju,Jiangtao Gao,James R. Doroghazi,Kwo-Kwang A. Wang,Christopher J. Thibodeaux,Steven Li,Emily Metzger,John Fudala,Joleen Su,Jun Kai Zhang,Jaeheon Lee,Joel P. Cioni,Bradley S. Evans,Ryuichi Hirota,David P. Labeda,Wilfred A. van der Donk,William W. Metcalf
标识
DOI:10.1073/pnas.1500873112
摘要
Significance The discovery of natural products, an important source of human medicines, is critical for the development of new therapeutics against health threats, including cancer and multidrug-resistant pathogens. Yet, in recent years, industrial development of pharmaceuticals from natural products has been stymied due to a variety of reasons, including the repeated discovery of previously known compounds. Here, we demonstrate large-scale genomics as one potential solution to this problem by mining a collection of 10,000 actinomycetes for novel phosphonic acids, an important class of natural products with antimicrobial, antiviral, antimalarial, and herbicidal activities. The framework described here provides a foundation for rapid, large-scale discovery of other classes of natural products and their use as lead compounds in the pharmaceutical industry.
科研通智能强力驱动
Strongly Powered by AbleSci AI